Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALISON A FISCHER

Allopathic & Osteopathic Physicians Dermatology

NPI
1225266307
CMS profile
512230
Location
TULSA, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$3,768.86

188 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,425.90 182
Education $342.96 6

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALISON A FISCHER

NPI 1225266307 · CMS profile ID 512230

Allopathic & Osteopathic Physicians / Dermatology

TULSA, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1225266307?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALISON A FISCHER, NPI 1225266307, CMS profile ID 512230. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1225266307?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ALISON A FISCHER, NPI 1225266307, CMS profile ID 512230. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1225266307?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ALISON A FISCHER, NPI 1225266307, CMS profile ID 512230, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 188 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1225266307?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

188 matching records · $3,768.86 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 188 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 188.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $19.9609/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139610992 CMS
UCB, Inc. $3.3809/05/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155571981 CMS
E.R. Squibb & Sons, L.L.C. $22.5709/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101819632 CMS
ABBVIE INC. $14.8208/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103731367 CMS
Novartis Pharmaceuticals Corporation $8.4608/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086902943 CMS
E.R. Squibb & Sons, L.L.C. $5.7808/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101819614 CMS
UCB, Inc. $18.9608/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143433838 CMS
ABBVIE INC. $7.9708/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103731365 CMS
Organogenesis Inc. $45.1408/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145427455 CMS
Regeneron Healthcare Solutions, Inc. $15.9608/22/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114048125 CMS
ABBVIE INC. $9.5408/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103731363 CMS
Regeneron Healthcare Solutions, Inc. $20.7408/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114048123 CMS
Arcutis Biotherapeutics, Inc. $13.5908/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1121033700 CMS
Lilly USA, LLC $14.2108/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136020620 CMS
UCB, Inc. $3.9608/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143433833 CMS
Novartis Pharmaceuticals Corporation $12.9108/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086902939 CMS
Lilly USA, LLC $16.2708/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136023688 CMS
Lilly USA, LLC $8.1108/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136017381 CMS
STRATA Skin Sciences, Inc. $30.4708/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146580503 CMS
STRATA Skin Sciences, Inc. $11.0608/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146580505 CMS
GENZYME CORPORATION $24.7708/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139610978 CMS
E.R. Squibb & Sons, L.L.C. $19.2508/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101819606 CMS
Regeneron Healthcare Solutions, Inc. $29.5408/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114048121 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $17.4508/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152122726 CMS
Regeneron Healthcare Solutions, Inc. $90.0207/31/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114048119 CMS
Novartis Pharmaceuticals Corporation $12.9307/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086902937 CMS
UCB, Inc. $13.8907/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143433829 CMS
PFIZER INC. $23.2907/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130890561 CMS
Incyte Corporation $15.8207/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141235949 CMS
Organogenesis Inc. $20.2107/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145427453 CMS
Novartis Pharmaceuticals Corporation $17.7107/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086902935 CMS
Regeneron Healthcare Solutions, Inc. $5.7007/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114048117 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $99.9907/11/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152122718 CMS
ABBVIE INC. $8.3907/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103731361 CMS
GENZYME CORPORATION $28.7407/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139610980 CMS
UCB, Inc. $13.3707/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1143433825 CMS
E.R. Squibb & Sons, L.L.C. $12.9507/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101819595 CMS
E.R. Squibb & Sons, L.L.C. $18.7807/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101819610 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $18.1207/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152122724 CMS
MAYNE PHARMA COMMERCIAL LLC $3.9207/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154678881 CMS
Sandoz Inc. $16.9007/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089373155 CMS
ABBVIE INC. $15.8306/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103731359 CMS
Lilly USA, LLC $17.2506/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136023692 CMS
ABBVIE INC. $21.2106/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103731357 CMS
MAYNE PHARMA COMMERCIAL LLC $8.2606/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154678877 CMS
Organogenesis Inc. $39.4006/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145427451 CMS
Lilly USA, LLC $13.0306/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135996946 CMS
E.R. Squibb & Sons, L.L.C. $17.4406/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101819591 CMS
Lilly USA, LLC $19.2706/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1136025830 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.6806/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117922990 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,691.76 84
PY2020 $942.45 48
PY2021 $1,919.90 109
PY2022 $2,970.93 164
PY2023 $3,330.68 154
PY2024 $3,768.86 188
PY2025 $3,463.02 202

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $11,848.40 2
PY2025 Principal investigator $31,828.52 5
PY2024 Principal investigator $74,214.05 18
PY2023 Recipient $5,122.00 1
PY2023 Principal investigator $154,790.68 28
PY2022 Principal investigator $249,214.34 46
PY2021 Principal investigator $389,393.10 71
PY2020 Principal investigator $364,997.19 53
PY2019 Principal investigator $178,029.99 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $3,600.00 12/09/2025 Non-covered Recipient Entity
Dermatology Research Center of Oklahoma
Randomised, double-blind, placebo-controlled, Phase IIb/Phase III study to evaluate the efficacy and safety of spesolimab in patients with moderate to severe hidradenitis suppurativa. Lunsayil 1. No dispute reported 06/30/2026 1220814711
Principal investigator 1 Amgen Inc. $4,639.00 08/23/2025 Non-covered Recipient Entity
DERMATOLOGY RESEARCH CENTER OF OKLAHOMA, PLLC
A Phase 3, Multi-center, Open-label, Single-arm Study to Assess the Safety of Apremilast (AMG 407) in Pediatric Participants From 6 Through 17 Years of Age With Mild to Moderate Plaque Psoriasis No dispute reported 06/30/2026 1246640739
Principal investigator 1 Amgen Inc. $16,668.00 08/01/2025 Non-covered Recipient Entity
DERMATOLOGY RESEARCH CENTER OF OKLAHOMA, PLLC
A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Effect of Rocatinlimab on Vaccine Antibody Response in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) No dispute reported 06/30/2026 1246640733
Recipient SANOFI US SERVICES INC. $630.00 06/09/2025 Covered Recipient Physician An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1226092564
Principal investigator 1 Amgen Inc. $2,000.00 06/04/2025 Non-covered Recipient Entity
DERMATOLOGY RESEARCH CENTER OF OKLAHOMA, PLLC
A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) No dispute reported 06/30/2026 1246640735
Recipient SANOFI US SERVICES INC. $11,218.40 05/05/2025 Covered Recipient Physician An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1226092560
Principal investigator 1 Amgen Inc. $4,921.52 01/06/2025 Non-covered Recipient Entity
DERMATOLOGY RESEARCH CENTER OF OKLAHOMA, PLLC
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) No dispute reported 06/30/2026 1246640737